Evaluation and Management of Granulomatous Lymphadenitis
For children with nontuberculous mycobacterial (NTM) cervical lymphadenitis, excisional surgery without chemotherapy is the definitive treatment with a 95% cure rate, while tuberculosis must be excluded first through tuberculin skin testing, chest radiography, and culture. 1
Initial Diagnostic Evaluation
Critical First Steps
Distinguish tuberculosis from NTM lymphadenitis immediately - this determines whether public health tracking and mandatory drug therapy are required versus surgical management alone 1.
Essential History Elements
- TB exposure risk: Family history, foreign-born status, recent immigration
- Age: Children <3 years suggest NTM (especially MAC); adults >90% TB 1
- Location: Unilateral cervical nodes (95% NTM); bilateral suggests other etiologies
- Systemic symptoms: Fever, night sweats, weight loss suggest TB or disseminated disease 1
- Immunosuppression status: HIV, transplant, chronic steroids increase risk of disseminated MAC or M. haemophilum 1
Required Diagnostic Tests
Tuberculin skin test (PPD) on all patients 1
- NTM lymphadenitis: Variable (negative to 10+ mm in one-third of cases)
- TB lymphadenitis: Typically strongly positive (≥15 mm)
Chest radiograph - must be normal in NTM lymphadenitis 1
Family TB screening - PPD testing of household contacts 1
Tissue diagnosis via excisional biopsy (NOT fine needle aspiration or incision/drainage) 1
- Send for: AFB smear, mycobacterial culture, histopathology
- Critical: Cultures positive in only 50-82% of cases despite compatible histology 1
Special Diagnostic Considerations
For preauricular lymph nodes: Excisional biopsy carries significant facial nerve injury risk - consider medical therapy if surgical risk is high 1
For immunosuppressed patients: Consider M. haemophilum - requires special hemin-supplemented media at 28-30°C 1
Management Algorithm
Pediatric NTM Cervical Lymphadenitis (MAC, M. scrofulaceum)
Primary treatment: Complete surgical excision without chemotherapy 1
- Success rate: ~95% 1
- Avoid: Incisional biopsy alone or anti-TB drugs without macrolide (leads to sinus tracts and chronic drainage) 1
For recurrent disease or high surgical risk:
- Clarithromycin-based multidrug regimen:
- Clarithromycin 1,000 mg (or weight-appropriate dose)
- Rifampin 600 mg
- Ethambutol 25 mg/kg
- Duration: Same as pulmonary MAC disease 1
When PPD is Strongly Positive (≥15 mm)
Start anti-TB therapy immediately while awaiting culture results, especially with TB risk factors 1
- If cultures negative for mycobacteria AND no TB risk factors: Discontinue anti-TB therapy
- If cultures grow NTM: Switch to appropriate NTM regimen
Adult Extrapulmonary MAC Disease
Combined surgical debridement PLUS chemotherapy 1
Drug regimen (same as MAC pulmonary disease):
- Clarithromycin 1,000 mg daily OR Azithromycin 250 mg daily
- Rifampin 600 mg daily OR Rifabutin 150-300 mg daily
- Ethambutol 15 mg/kg daily
- Duration: 6-12 months 1
Tuberculous Lymphadenitis
Standard TB chemotherapy required 1
- Isoniazid, rifampin, pyrazinamide, ethambutol for 2 months
- Followed by isoniazid and rifampin for 4 months
- Public health notification mandatory 1
Common Pitfalls to Avoid
Never perform incision and drainage or incisional biopsy alone - leads to fistula formation and chronic drainage 1
Never use anti-TB drugs without a macrolide for NTM - inadequate coverage leads to treatment failure 1
Never assume NTM based on negative PPD alone - one-third of NTM cases have ≥10 mm induration 1
Never skip mycobacterial cultures - definitive diagnosis requires organism identification 1
For M. haemophilum: Must specifically request hemin-supplemented media; routine AFB cultures will be falsely negative despite positive smears 1
Special Populations
HIV/Immunosuppressed Patients
- Consider disseminated MAC (requires clarithromycin + ethambutol ± rifabutin) 1
- Immune reconstitution syndrome can present as lymphadenitis 1
- M. haemophilum more common in transplant recipients 1
Geographic Considerations
Recent studies show etiology varies by region: